Table 5.

Heat Responses (%CVC_max) Catheter 4

Heat Event	Medication	Control Subjects (N=12)	POTS Patients (N=12)
Baseline	Pre Drugs	12±1	5±1*
	Ang-(1–7)	10±3	15±5†
First Thermal Peak	Pre Drugs	63±6	45±4*
	Ang-(1–7)	70±4	58±7
Nadir	Pre Drugs	35±5	23±5
	Ang-(1–7)	43±6	56±7†
Plateau	Pre Drugs	84±5	29±5*
	Ang-(1–7)	91±5	74±4*†

^*p<0.05 different from control subjects. %CVC= percent cutaneous vascular conductance.

^†p<0.05 different from pre-drug